Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical

Zhi-Ning Ye1, Guy D Eslick2, Shao-Gang Huang3

  • 1The Affiliated Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, China.

Egastroenterology
|February 13, 2025
PubMed

Insights

Faecal microbiota transplantation (FMT) shows promise for eradicating Helicobacter pylori (H. pylori) infections, offering a new approach when antibiotics fail. Research is ongoing to optimize FMT protocols for maximum effectiveness against H. pylori.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Immunology

Background:

  • Antibiotic resistance is decreasing the effectiveness of standard treatments for *Helicobacter pylori* (*H. pylori*) infections.
  • Single probiotic administration has shown minimal success in eradicating *H. pylori*.

Purpose of the Study:

  • To review the efficacy of faecal microbiota transplantation (FMT) as a therapeutic strategy for *H. pylori* eradication.
  • To explore the potential mechanisms and influencing factors of FMT in treating *H. pylori* infection.

Main Methods:

  • Review of existing literature on FMT for *H. pylori* eradication.
  • Analysis of FMT's role as monotherapy and adjunctive therapy.

Main Results:

  • FMT demonstrates beneficial effects in eradicating *H. pylori* and preventing adverse events.
  • The efficacy of FMT may be attributed to various components within the fecal suspension, such as microbes and metabolites.
  • Donor selection, preparation, and delivery methods significantly impact FMT effectiveness.

Conclusions:

  • FMT presents a promising therapeutic option for *H. pylori* infection, particularly in the context of rising antibiotic resistance.
  • Further research is needed to optimize FMT procedures and elucidate its precise mechanisms of action against *H. pylori*.

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.4K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
320
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
375
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
80
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
60